Navigation Links
Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months


and first nine months of $63,265 and $202,048, respectively, compared

with $60,630 and $193,864 for the prior year.

(2) The average number of common shares outstanding for diluted earnings

per share is higher than for basic earnings per share due to the

assumed conversion of the Company's outstanding convertible senior

debentures, outstanding stock options, deferred contingent common

stock awards, restricted stock awards and convertible preferred stock

into common stock equivalents using the treasury stock method. For

purposes of calculating diluted earnings per share, interest expense,

net of capitalized interest and taxes related to the Company's

outstanding convertible senior debentures is added back to reported

net income, and the additional common shares (assuming conversion) are

included in total shares outstanding. Interest expense, net of

capitalized interest and taxes was $7,838 and $23,617 for the 2007

third quarter and first nine months, respectively, compared with

$8,100 and $21,841 for the 2006 third quarter and first nine months,


(3) Charges related to activities associated with the Company's

productivity initiatives and the 2006 income tax adjustment are

considered certain significant items and have been excluded from the

results of operations - as adjusted for the 2007 and 2006 third

quarter and first nine months as follows:

Productivity Initiatives


Three Months Ended Nine Months Ended

(In thousands, except

per share amounts) 9/30/2007 9/30/2006 9/30/2007 9/30/2006

Cost of Goods Sold $111,200 $31,300 $182,400 $86,500

Selling, General

Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy
3. Wyeth Pharma Wins Law Suit
4. Verdict Against Wyeth Pharma in Prempro Case
5. FDA Approves Wyeths Oral Contraceptive Lybrel
6. Autopsy reports could be valuable and informative
7. China reports declining number of SARS Cases
8. Russia Reports First SARS Case
9. Research reports that c-section deliveries are rising
10. Jharkhand reports 13,000 Malaria cases
11. Uganda Reports Failure To Contain Sleeping Sickness
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Head Over Heels Athletic Arts gymnast, ... camp at the Karolyi Ranch in Huntsville, Texas on October 17-21. , "It's ... girls team head coach and executive director, said. “It's a stepping stone into the ...
(Date:10/9/2015)... ... October 09, 2015 , ... On Saturday, September 26, 2015, 48-year-old ... Championship in Madrid, Spain. Representing both the USA and Sweden in the Speed and ... One-Minute Am Front Crosses, she was awarded 1 Silver and 4 Gold Medals. , ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... “Agents of Change” program, a community improvement initiative that involves working with a ... benefit from the assistance of Confidence Plus Insurance is the Gleason Park Electric ...
(Date:10/9/2015)... PA (PRWEB) , ... October 09, 2015 , ... "As ... of two inventors from Philadelphia, Pa. "They have to wear large diapers or pads. ... solutions." , They developed the TROUSAFE to absorb urine leaking from the tip of ...
(Date:10/9/2015)... ... October 09, 2015 , ... MMJ PhytoTech Limited announced ... Begley Jr., airing 1st QT 2016 via the Discovery Channel. Dates and show ... Limited (MMJ) – a global leader in the field of commercializing medicinal grade ...
Breaking Medicine News(10 mins):
... mutate for a living, evading antibiotic drugs while killing tens ... But as concern about drug-resistant bacteria grows, one novel approach ... Hill seeks to thwart the bug without a drug by ... his lab of analytical chemists at UNC have created nano-scale ...
... Fourth Quarter 2007 Revenue Increases 32% to $14.2 Million ... Profit Margin at 58.2% Sets Quarterly Record, MINNEAPOLIS, Feb. ... marketer of state-of-the-art cardiac,surgery products and services, today reported financial ... 2007. Revenue for the,quarter was $14.2 million, up 32.4% from ...
... effectiveness of these breast cancer detection methods, study says ... combined hormone therapy for about five years have a higher ... turn, may decrease the effectiveness of these methods of detecting ... Feb. 25 issue of Archives of Internal Medicine . ...
... Aram,will lend his support to another noteworthy cause, The Naz ... flagship store on March,13th for a special benefit event., ... charity that was,established in 1994, at a time when the ... itself to raising awareness on and,preventing the local spread of ...
... Influenza and ... MRSA., ... SEAL(TM) Washable, Antimicrobial Mouse at the HiMSS,Healthcare Symposium in Orlando, FL. According ... to be fully submersible,dishwasher safe, and manufactured from SILVER SEAL(TM) Antimicrobial,plastic. The ...
... Feb. 25 The Quantum Group,Inc. (Amex: QGP, ... J. Guillama, President & CEO, will present at ... Thursday, February 28, 2008, which will,be held at ... The presentations will be held in the Grand ...
Cached Medicine News:
(Date:10/8/2015)...  Trovagene, Inc., (NASDAQ:   TROV) a developer ... of results from a field experience analysis featuring ... (PCM) platform to accurately identify mutational status, ... appropriate therapy for patients. Mark Erlander , ... the results today in an oral presentation titled ...
(Date:10/8/2015)... October 8, 2015 " Biomedical ... Growth, Trends and Forecast 2014 - 2022 " , ... 2.63 billion in 2013 and is anticipated to expand at ... USD 4.00 billion in 2022. --> " ... Share, Growth, Trends and Forecast 2014 - 2022 " ...
(Date:10/8/2015)... , Oct. 08 2015 ... addition of the "Natural Language Processing ... Industry by Type (Rule-Based, Statistical, & Hybrid ... Middle East and Africa, Latin America) - ... their offering. --> ) ...
Breaking Medicine Technology:
... The U.S. Food and Drug Administration today announced that monthly ... Letairis tablets (ambrisentan), used to treat high blood pressure in ... hypertension, or PAH). (Logo: ) ... the FDA said that the drug poses only a low ...
... 4, 2011 Sigma-Aldrich Corporation (Nasdaq: SIAL ) ... 31st Annual Cowen and Company Healthcare Conference ... Place, Boston, MA, presenting at 10:15 AM (EST). Barclays ... the Loews Miami Hotel, Miami, FL, presenting at 10:15 AM ...
Cached Medicine Technology:
... Anatomical Malar I Implants - Providing the ... follows the contour of the zygoma while ... Anatomical Malar II Implants - The ... surgeon with another augumentation option that adds ...
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... FL40 Centrifuge Series from Thermo Electron ... increase your productivity in the lab. ... rotors and accessories for high-volume blood ... IEC CL40 and FL40 Centrifuge Series ...
Medicine Products: